Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cardiac safety services can be defined as services that deal with supporting and designing clinical trials and other studies required for the monitoring of cardiac safety.Cardiac safety services are focused on monitoring the entire cardiac safety profile across various phases of clinical trials, including Phase I to Phase IV. These studies are done in compliance with FDA, PMDA, EMA, and other regulatory bodies.Cardiovascular safety assessment services include non-invasive cardiac imaging, physiologic stress testing, platelet aggregation, ambulatory blood pressure monitoring, and other services, along with the QT studies.Integrated services offering cardiac safety services are mostly preferred owing to the bundling of services with focus on end-to-end development, as compared to the specificity of standalone services
Global Cardiac Safety Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Safety Services market research.
Key companies engaged in the Cardiac Safety Services industry include Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc. and Ncardia AG, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cardiac Safety Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cardiac Safety Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiac Safety Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
by Service Type
Segment by Application
By Region
The Cardiac Safety Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Safety Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Integrated Services
1.2.3 Standalone Services
1.3 Market by Application
1.3.1 Global Cardiac Safety Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biopharmaceuticals Companies
1.3.3 Contract Research Organization(CRO)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Safety Services Market Perspective (2018-2029)
2.2 Cardiac Safety Services Growth Trends by Region
2.2.1 Global Cardiac Safety Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiac Safety Services Historic Market Size by Region (2018-2023)
2.2.3 Cardiac Safety Services Forecasted Market Size by Region (2024-2029)
2.3 Cardiac Safety Services Market Dynamics
2.3.1 Cardiac Safety Services Industry Trends
2.3.2 Cardiac Safety Services Market Drivers
2.3.3 Cardiac Safety Services Market Challenges
2.3.4 Cardiac Safety Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Safety Services Players by Revenue
3.1.1 Global Top Cardiac Safety Services Players by Revenue (2018-2023)
3.1.2 Global Cardiac Safety Services Revenue Market Share by Players (2018-2023)
3.2 Global Cardiac Safety Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Safety Services Revenue
3.4 Global Cardiac Safety Services Market Concentration Ratio
3.4.1 Global Cardiac Safety Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Safety Services Revenue in 2022
3.5 Cardiac Safety Services Key Players Head office and Area Served
3.6 Key Players Cardiac Safety Services Product Solution and Service
3.7 Date of Enter into Cardiac Safety Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Safety Services Breakdown Data by Type
4.1 Global Cardiac Safety Services Historic Market Size by Type (2018-2023)
4.2 Global Cardiac Safety Services Forecasted Market Size by Type (2024-2029)
5 Cardiac Safety Services Breakdown Data by Application
5.1 Global Cardiac Safety Services Historic Market Size by Application (2018-2023)
5.2 Global Cardiac Safety Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cardiac Safety Services Market Size (2018-2029)
6.2 North America Cardiac Safety Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiac Safety Services Market Size by Country (2018-2023)
6.4 North America Cardiac Safety Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Safety Services Market Size (2018-2029)
7.2 Europe Cardiac Safety Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiac Safety Services Market Size by Country (2018-2023)
7.4 Europe Cardiac Safety Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Safety Services Market Size (2018-2029)
8.2 Asia-Pacific Cardiac Safety Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiac Safety Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiac Safety Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Safety Services Market Size (2018-2029)
9.2 Latin America Cardiac Safety Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiac Safety Services Market Size by Country (2018-2023)
9.4 Latin America Cardiac Safety Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Safety Services Market Size (2018-2029)
10.2 Middle East & Africa Cardiac Safety Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiac Safety Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiac Safety Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotrial
11.1.1 Biotrial Company Detail
11.1.2 Biotrial Business Overview
11.1.3 Biotrial Cardiac Safety Services Introduction
11.1.4 Biotrial Revenue in Cardiac Safety Services Business (2018-2023)
11.1.5 Biotrial Recent Development
11.2 Banook Group
11.2.1 Banook Group Company Detail
11.2.2 Banook Group Business Overview
11.2.3 Banook Group Cardiac Safety Services Introduction
11.2.4 Banook Group Revenue in Cardiac Safety Services Business (2018-2023)
11.2.5 Banook Group Recent Development
11.3 Bioclinica
11.3.1 Bioclinica Company Detail
11.3.2 Bioclinica Business Overview
11.3.3 Bioclinica Cardiac Safety Services Introduction
11.3.4 Bioclinica Revenue in Cardiac Safety Services Business (2018-2023)
11.3.5 Bioclinica Recent Development
11.4 Certara L.P.
11.4.1 Certara L.P. Company Detail
11.4.2 Certara L.P. Business Overview
11.4.3 Certara L.P. Cardiac Safety Services Introduction
11.4.4 Certara L.P. Revenue in Cardiac Safety Services Business (2018-2023)
11.4.5 Certara L.P. Recent Development
11.5 Celerion, Inc
11.5.1 Celerion, Inc Company Detail
11.5.2 Celerion, Inc Business Overview
11.5.3 Celerion, Inc Cardiac Safety Services Introduction
11.5.4 Celerion, Inc Revenue in Cardiac Safety Services Business (2018-2023)
11.5.5 Celerion, Inc Recent Development
11.6 ERT, Inc
11.6.1 ERT, Inc Company Detail
11.6.2 ERT, Inc Business Overview
11.6.3 ERT, Inc Cardiac Safety Services Introduction
11.6.4 ERT, Inc Revenue in Cardiac Safety Services Business (2018-2023)
11.6.5 ERT, Inc Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Detail
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Cardiac Safety Services Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Cardiac Safety Services Business (2018-2023)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Medpace Holdings, Inc.
11.8.1 Medpace Holdings, Inc. Company Detail
11.8.2 Medpace Holdings, Inc. Business Overview
11.8.3 Medpace Holdings, Inc. Cardiac Safety Services Introduction
11.8.4 Medpace Holdings, Inc. Revenue in Cardiac Safety Services Business (2018-2023)
11.8.5 Medpace Holdings, Inc. Recent Development
11.9 Ncardia AG
11.9.1 Ncardia AG Company Detail
11.9.2 Ncardia AG Business Overview
11.9.3 Ncardia AG Cardiac Safety Services Introduction
11.9.4 Ncardia AG Revenue in Cardiac Safety Services Business (2018-2023)
11.9.5 Ncardia AG Recent Development
11.10 Richmond Pharmacology
11.10.1 Richmond Pharmacology Company Detail
11.10.2 Richmond Pharmacology Business Overview
11.10.3 Richmond Pharmacology Cardiac Safety Services Introduction
11.10.4 Richmond Pharmacology Revenue in Cardiac Safety Services Business (2018-2023)
11.10.5 Richmond Pharmacology Recent Development
11.11 PhysioStim
11.11.1 PhysioStim Company Detail
11.11.2 PhysioStim Business Overview
11.11.3 PhysioStim Cardiac Safety Services Introduction
11.11.4 PhysioStim Revenue in Cardiac Safety Services Business (2018-2023)
11.11.5 PhysioStim Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Detail
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Cardiac Safety Services Introduction
11.12.4 IQVIA Revenue in Cardiac Safety Services Business (2018-2023)
11.12.5 IQVIA Recent Development
11.13 BioTelemetry, Inc
11.13.1 BioTelemetry, Inc Company Detail
11.13.2 BioTelemetry, Inc Business Overview
11.13.3 BioTelemetry, Inc Cardiac Safety Services Introduction
11.13.4 BioTelemetry, Inc Revenue in Cardiac Safety Services Business (2018-2023)
11.13.5 BioTelemetry, Inc Recent Development
11.14 Pharmaceutical Product Development, LLC
11.14.1 Pharmaceutical Product Development, LLC Company Detail
11.14.2 Pharmaceutical Product Development, LLC Business Overview
11.14.3 Pharmaceutical Product Development, LLC Cardiac Safety Services Introduction
11.14.4 Pharmaceutical Product Development, LLC Revenue in Cardiac Safety Services Business (2018-2023)
11.14.5 Pharmaceutical Product Development, LLC Recent Development
11.15 Shanghai Medicilon Inc
11.15.1 Shanghai Medicilon Inc Company Detail
11.15.2 Shanghai Medicilon Inc Business Overview
11.15.3 Shanghai Medicilon Inc Cardiac Safety Services Introduction
11.15.4 Shanghai Medicilon Inc Revenue in Cardiac Safety Services Business (2018-2023)
11.15.5 Shanghai Medicilon Inc Recent Development
11.16 SGS SA
11.16.1 SGS SA Company Detail
11.16.2 SGS SA Business Overview
11.16.3 SGS SA Cardiac Safety Services Introduction
11.16.4 SGS SA Revenue in Cardiac Safety Services Business (2018-2023)
11.16.5 SGS SA Recent Development
11.17 Spaulding Clinical Research, LLC
11.17.1 Spaulding Clinical Research, LLC Company Detail
11.17.2 Spaulding Clinical Research, LLC Business Overview
11.17.3 Spaulding Clinical Research, LLC Cardiac Safety Services Introduction
11.17.4 Spaulding Clinical Research, LLC Revenue in Cardiac Safety Services Business (2018-2023)
11.17.5 Spaulding Clinical Research, LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
Published By : QY Research